Agilent Technologies (NYSE:A – Get a score) issued an update on its fourth-quarter earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.38-$1.40 for the period, compared to the consensus estimate of $1.34. The company issued revenue guidance of $1.75 billion-$1.775 billion, compared to the consensus revenue estimate of $1.77 billion. Agilent Technologies also upgraded its FY2022 guidance to $5.06-$5.08 EPS.
Analyst Updates and Downgrades
A has been the subject of a number of recent research reports. Robert W. Baird increased their price objective on shares of Agilent Technologies from $155.00 to $161.00 and gave the company an outperform rating in a research note on Wednesday, May 25th. . StockNews.com raised shares of Agilent Technologies from a buy rating to a strong-buy rating in a report on Wednesday, August 3rd. KeyCorp reduced their price objective on Agilent Technologies from $195.00 to $155.00 and set an overweight rating for the company in a research report on Thursday, June 2nd. Goldman Sachs Group cut their price target on shares of Agilent Technologies from $170.00 to $140.00 and set a buy rating on the stock in a research note on Thursday, July 14th. Finally, UBS Group initiated coverage on shares of Agilent Technologies in a research report on Wednesday, July 20th. They set a buy rating and a $139.00 target price on the stock. Four analysts have rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Agilent Technologies has an average rating of Moderate Buy and an average target price of $152.75, according to data from MarketBeat.com.
Agilent Technologies Price Performance
Ad Weiss ratings
How To Get ANOTHER 80% Off Top Cryptos
Crypto markets have already fallen a lot. But we have a secret technique that can lead you to some of the most promising coins at even bigger discounts. Doing it now could set you up for absolutely massive gains when the new bull market starts to take off… Just click here to find out how it works.
Shares of NYSE:A traded down $1.13 during midday trading on Tuesday, reaching $132.77. The stock had a trading volume of 1,668,670 shares, compared to its average volume of 1,890,555. The company’s 50-day moving average price is $123.23 and its 200-day moving average price is $127.54. The company has a market cap of $39.66 billion, a P/E ratio of 31.99, a price-to-earnings-growth ratio of 2.74 and a beta of 1.06. The company has a quick ratio of 1.49, a current ratio of 2.01, and a debt-to-equity ratio of 0.53. Agilent Technologies has a fifty-two week low of $112.52 and a fifty-two week high of $179.57.
Agilent Technologies (NYSE:A – Get a score) last announced its quarterly earnings results on Tuesday, August 16th. The medical research company reported $1.34 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.21 by $0.13. The company had revenue of $1.72 billion during the quarter, compared to analyst estimates of $1.64 billion. Agilent Technologies had a net margin of 19.35% and a return on equity of 27.42%. The company’s revenue increased by 8.3% year-on-year. During the same period in the previous year, the company posted EPS of $1.10. As a group, equities research analysts predict that Agilent Technologies will post 4.88 EPS for the current fiscal year.
Agilent Technologies announces dividend
The company also recently declared a quarterly dividend, which was paid on Wednesday, July 27th. Stockholders of record on Tuesday, July 5th were given a dividend of $0.21 per share. The ex-date of this dividend was Friday, July 1st. This represents an annualized dividend of $0.84 and a yield of 0.63%. Agilent Technologies’s payout ratio is 20.24%.
Privileged activity at Agilent Technologies
In other news, VP Jacob Thaysen sold 5,879 shares of the company’s stock in a transaction that occurred on Thursday, June 2nd. The shares were sold at an average price of $127.43, for a total transaction of $749,160.97. Following the completion of the sale, the vice president now owns 88,737 shares of the company’s stock, valued at approximately $11,307,755.91. The sale was disclosed in a legal filing with the SEC, which can be accessed this link. In other news, VP Jacob Thaysen sold 5,879 shares of Agilent Technologies stock in a transaction dated Thursday, June 2nd. The shares were sold at an average price of $127.43, for a total transaction of $749,160.97. Following the completion of the transaction, the vice president now directly owns 88,737 shares in the company, valued at $11,307,755.91. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed this link. Also, VP Padraig McDonnell sold 1,000 shares of the company’s stock in a transaction that occurred on Thursday, June 30th. The shares were sold at an average price of $118.62, for a total value of $118,620.00. Following the completion of the transaction, the vice president now owns 17,826 shares in the company, valued at approximately $2,114,520.12. Disclosure of this sale can be found here.
Agilent Technologies Institutional Trade
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Orion Portfolio Solutions LLC grew its position in Agilent Technologies by 12.3% during the first quarter. Orion Portfolio Solutions LLC now owns 2,880 shares of the medical research company’s stock worth $381,000 after purchasing an additional 315 shares during the last quarter. Zions Bancorporation NA boosted its position in shares of Agilent Technologies by 10.8% during the first quarter. Zions Bancorporation NA now owns 2,880 shares of the medical research company’s stock valued at $381,000 after buying an additional 281 shares during the last quarter. Horizon Investments LLC raised its stake in Agilent Technologies by 12.6% during the first quarter. Horizon Investments LLC now owns 2,696 shares of the medical research company’s stock worth $356,000 after purchasing an additional 302 shares during the last quarter. Fund management of Engine No. 1 LLC purchased a new stake in Agilent Technologies during the 1st quarter valued at approximately $336,000. Finally, Mather Group LLC. raised its holdings in shares of Agilent Technologies by 13.5% during the first quarter. Mather Group LLC. now owns 2,487 shares of the medical research company’s stock worth $329,000 after purchasing an additional 296 shares during the period.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application-focused solutions to the life sciences, diagnostics and applied chemicals markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate-based assays; flow cytometer; real-time cell analyzer; cellular imaging systems; microplate reader; laboratory software; management and analysis of information; laboratory automation and robotic systems; dissolution tests; vacuum pumps and measurement technologies.
This instant news alert was powered by MarketBeat’s narrative science technology and financial data to provide readers with the fastest and most accurate reporting. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to firstname.lastname@example.org.
Before you consider Agilent Technologies, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients daily. MarketBeat has identified the five stocks that top analysts are quietly telling their clients to buy now before the broader market takes notice … and Agilent Technologies wasn’t on the list.
Although Agilent Technologies currently has a “Moderate Buy” rating among analysts, the top rated analysts believe these five stocks are best buys.
Check out the five stocks here